BioSig Technologies, Inc. announces its intention to offer shares of common stock (or pre-funded warrants) through an underwritten public offering.
The offering is subject to market conditions and the company plans to use the proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Offer Details
The offering includes shares of common stock or pre-funded warrants, with the intent to purchase gold bullion and support corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as the joint book-running managers of the offering.
SEC Registration
The offering follows a shelf registration statement on Form S-3 (File No. 333-276298) declared effective by the SEC on December 17, 2024.
- BioSig Technologies aims to raise funds through the public offering to support its investment policy, working capital, and general corporate needs.
- The involvement of Clear Street and Needham & Company as book-running managers indicates strong support for the offering.
The proposed public offering by BioSig Technologies reflects the company's strategic move to raise capital for specific purposes outlined in the filing. The involvement of reputable book-running managers adds further credibility to the offering process.